Event: Welcome to our new coworking and meeting place at Campus Flemingsberg

Stockholm aims to become a world-leading life science cluster. To succeed, the city needs expertise, research facilities, cooperation and cross-border meeting places where creative collaborations can occur.

Welcome to a launch event where we will shed light on what’s needed to set us all on the right path. A Working Lab is a new, key meeting point in that ecosystem. Here, companies, students and scientists can rent labs and office space with flexible contracts. Welcome to our newly opened AWL node which connects KI, life science industry, Campus Flemingsberg and Solna.

PROGRAM
– Welcome to A Working Lab Flemingsberg
Sara Gunnerås KI Science Park, Johnny Högberg Flemingsberg Science, Åsa Johansson AWL
– Success factors for a leading life science cluster, Martin Tegner Region Sthlm
– A place for collaboration, Lars Frelin Ana Futura
– Panel discussion with A Working Lab members APLEX Bio and Truly Labs
– Tie the knot!

– Mingle, food, drinks, music and the chance to see the coworking space

Moderator: Patrik Blomquist, KI Innovations

The event is organised by A Working Lab om cooperation with Flemingsberg Science and KI Science Park.

Time: 2022-10-27 at 14.00-15.15

Place: Lounge, AWL Flemingsberg, Alfred Nobels Allé 10,

Register here!

Published On: 17 October 2022
  • Navigating the life science ecosystem

    Have you considered what support and opportunities are available to [...]

  • Developing new ways to treat nerve damage and chronic pain using the body’s own proteins

    Sinfonia Biotherapeutics uses the body’s reparative proteins to develop effective [...]

  • SISP deepens innovation collaboration in Flemingsberg

    During the spring, Flemingsberg Science approached Swedish Incubators and Science [...]

  • Life Tech guides companies to the region’s research infrastructures

    The Stockholm Life Tech project achieved its goal in the [...]

  • Breakthrough for AlzeCure in the development of drugs for nerve pain

    AlzeCure Pharma shows positive results from its clinical study with [...]